Q32 Bio Target Price

Where could QTTB trade next? Consensus target price: $44.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.22

Average Target Price

$44.00

377.2% upside

4 analysts in the last 4 months

High: $66 | Low: $34

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-24	Morgan StanleyJudah Frommer	$34	268.8% upside
2026-07-28	H.C. WainwrightJoseph Pantginis	$36	290.5% upside
2026-07-13	Wells FargoDerek Archila	$66	615.8% upside
2026-07-13	Oppenheimer	$40	333.8% upside
2026-05-22	Mizuho SecuritiesJoseph Catanzaro	$14	51.8% upside
2026-03-10	H.C. WainwrightJoseph Pantginis	$13	41% upside
2024-12-05	BMO CapitalEtzer Darout	$64	594.1% upside
2024-10-16	OppenheimerJay Olson	$80	767.7% upside
2024-09-11	Wells FargoDerek Archila	$95	930.4% upside
2024-05-21	Leerink PartnersThomas Smith	$54	485.7% upside
2024-04-10	OppenheimerJay Olson	$50	442.3% upside
2024-04-02	Raymond JamesChristopher Raymond	$45	388.1% upside
2024-04-02	Piper SandlerAllison Bratzel	$45	388.1% upside

Q32 Bio (QTTB) FAQ

As of the most recent data, QTTB shows a target price of $44. Scroll down for historical charts and peer comparison views.

If Q32 Bio moved to the average analyst target of $44, shares would be roughly 377.2% higher than $9.22. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Q32 Bio's earnings trajectory.

Besides this target price page, Stockcircle has Q32 Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $44) with ownership activity and broader fundamentals.

Q32 Bio's target price is $44; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.